Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study.

MLA

Riva, Eloísa, et al. “Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study.” JCO Global Oncology, vol. 8, Aug. 2022, p. e2100380. EBSCOhost, https://doi.org/10.1200/GO.21.00380.

APA

Riva, E., Duarte, P. J., Valcárcel, B., Remaggi, G., Murrieta, I., Corzo, A., Del Carpio, D., Peña, C., Vásquez, J., Bove, V., Teixeira, L., Fleury-Perini, G., Yantorno, S., Samánez, C., Lopresti, S., Altamirano, M., Villela, L., Ruiz-Arguelles, G. J., Ruiz-Delgado, G. J., … Malpica Castillo, L. E. (2022). Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study. JCO Global Oncology, 8, e2100380. https://doi.org/10.1200/GO.21.00380

Chicago

Riva, Eloísa, Patricio José Duarte, Bryan Valcárcel, Guillermina Remaggi, Ivan Murrieta, Ariel Corzo, Daniel Del Carpio, et al. 2022. “Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study.” JCO Global Oncology 8 (August): e2100380. doi:10.1200/GO.21.00380.